Flashcards
QuintilesIMS Institute 2016: Outlook for Global Medicine through 2021
Cards in this deck (23)
- 1What is CRISPRclustered regulatory interspaced palindromic short repeats
gene editing to directly modify disease related changes in genome - 2What is CAGRcompound annual growth rate
measure of growth over multiple time periods; growth rate from the initial investment value to the ending investment value if you assume that the investment has been compounding over the time period. - 3CAGR for US through 20214-7%
- 4What is the reduction in overall spending over the next five years$143.5 billion
- 5how does this compare to previous 5 years1.5 times the impace as in the past five years
- 6What major contributors cause this impactloss of exclusivity and introduction of biosimilars
- 7Pricing and Growth in EuropePricing and Growth in Europe
- 8What are the EU5France
Italy
Germany
Spain
United Kingdom - 9What is BREXITBritish exit from the European Union (2016)
- 10How does BREXIT affect on the UK pharmaceutical marketmodestly: 1.5 % slower growth rate in the downside scenario
- 11BY THE NUMBERSBY THE NUMBERS
- 12Transformations in Disease TreatmentsTransformations in Disease Treatments
- 13evolution of new platformsCRISPR
harnessing power of gut microbiome
regenerative cell tech - 14what are the immune checkpoint inhibitors that will most contribute to growth of the market in the next 5 yearsCTLA4
PD1 inhibitors (nivolumab and pembrolizumab) - 15What combination drugs are being tried for NSCLCanti PDL1 atezolizumab (Tecentriq) + nivolumab (Opdivo) + platinum based doublet chemotherapy
PD1 combination pemetrexed, pembrolizumab (Keytruda), and carboplatin - 16Trends in US medicinesTrends in US medicines
- 17How do UK and germany control growth in their pharma marketlimit sales of new medicines and trigger negotiations to avoid the unexpected budet busters of the last two years
- 18How does France control growth in their pharma marketseek lower prices, greater generic usage, and additional reforms to the payback system where manufacturers repay the government if drug spend exceeds set levels
- 19How does italy control growth in their pharma marketshifting spending to the hospital sector where government budgeting has greater direct control
- 20How does spain control growth in their pharma marketdevolved regional budgeting
- 21impact on growth from brexit1.5% slower growth
- 22why does controlling healthcare spending in pharma matterintend to balance desirable medical progress with a nation's ability to pay on a sustainable basis
- 23—
Information
- Description
- Sanofi Flashcards on QuintilesIMS Institute 2016: Outlook for Global Medicine through 2021, created by Shane Naki on 11/01/2017.
- Created by
- Shane Naki
- Views
- 21
- Tags
- Rating